GCV Rising Star Paulo Braga, who leads Eurofarma’s corporate venturing fund, has spoken to Global Corporate Venturing about the unit's focus.

Brazil-based pharmaceutical firm Eurofarma’s corporate venture capital (CVC) arm seeks to identify digital technologies that can disrupt the healthcare ecosystem, Paulo Braga, head of the unit, told Global Corporate Venturing. The vehicle was formed last month and has the capacity to invest up to R$45m ($11.7m) in early-stage healthcare technology developers. “We do not focus…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.